NASDAQ · Biotechnology

LEXX (LEXX) Stock

$0.56 +7.36% NASDAQ: LEXX Healthcare

Valuation

MetricValue
Price$0.56
Market Cap$13.88M
P/E Ratio-0.92
P/B Ratio4.16
P/S Ratio32.03
EPS (TTM)$-0.66
52-Week High$1.55
52-Week Low$0.46
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-400.00%
ROA-300.00%
ROCE-600.00%
Gross Margin-1100.00%
Operating Margin-1200.00%
Net Margin-25.90%
Debt/Equity0.01
Current Ratio3.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$0$0$0$1.0M
Operating Profit$-6.0M$-7.0M$-7.0M$-6.0M$-12.0M
Net Profit$-4.0M$-7.0M$-7.0M$-6.0M$-12.0M
EPS$-0.92$-1.24$-1.01$-0.47$-0.66
Op Margin-763.8%-2545.4%-2888.5%-1226.7%-1648.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$8.0M$3.0M$9.0M$4.0M
Total Liabilities$0$0$0$1.0M$2.0M
Cash$11.0M$6.0M$1.0M$6.0M$2.0M
Borrowings$0$0$0$0$0

Latest News

LEXX: Dosing Started for Animal & Human GLP-1 Studies Zacks Small Cap Research · Jul 17, 2026 Lexaria Updates Business Development ACCESS Newswire · Jul 6, 2026 Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule ACCESS Newswire · Jun 25, 2026 Lexaria's Animal Study GLP-1-A26-1 Has Begun Dosing on Schedule ACCESS Newswire · Jun 23, 2026 GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand ACCESS Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-4.0M$-5.0M$-6.0M$-5.0M$-10.0M
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$4.0M$0$0$6.0M$0
Net Cash Flow$10.0M$-5.0M$-4.0M$5.0M$-5.0M
Free Cash Flow$-4.0M$-5.0M$-6.0M$-5.0M$-10.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-80.00%
Quick Ratio26.88
Interest Coverage—
Return 1Y-27.84%
Return 3Y-28.97%
Return 5Y-90.98%

Ownership

Insiders Held3.32%
Institutions Held6.03%
Institutions Float Held6.23%
Institutional HolderSharesReport Date
Invenomic Capital Management, LP442,3012026-03-31
Geode Capital Management, LLC294,1572026-03-31
Vanguard Capital Management LLC222,2932026-03-31
Toronto Dominion Bank140,0132026-03-31
Vanguard Fiduciary Trust Co94,1662026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLR $1.39 -0.71% -1.91 $22.12M 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%

About LEXX

LEXX is led by CEO Richard C. Christopher, publicly traded since 2021.

LEXX stock trades at $0.56 with a market capitalization of $13.88M. The stock is valued at a price-to-earnings (P/E) ratio of -0.92, price-to-book of 4.16, price-to-sales of 32.03. Over the past 52 weeks the stock has ranged between $0.46 and $1.55, and currently trades 63.9% below its 52-week high.

On profitability, LEXX generates a return on equity (ROE) of -400.00%, return on capital employed of -600.00%, an operating margin of -1200.00%, a net profit margin of -25.90%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides